U.S. Oncology Information Systems Market Summary

The U.S. oncology information systems (OIS) market size was valued at USD 900.29 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.40% from 2025 to 2030. The rising prevalence of cancer across multiple demographic groups, coupled with the growing demand for advanced oncology information systems, serves as a major driver of the industry. Deployment of these solutions is particularly high in hospitals and cancer research institutes across the U.S., driven by the rising number of cancer diagnoses and the increasing healthcare expenditure dedicated to improving cancer care infrastructure.

The U.S. oncology information systems industry is poised for substantial expansion due to the integration of healthcare IT and the growing cancer burden. According to the National Cancer Institute, more than 2 million new cancer cases are expected to be diagnosed in the U.S. in 2024, with approximately 611,720 cancer-related deaths projected for the year. This surge in disease incidence highlights the pressing need for advanced data management systems, real-time analytics, and clinical decision support tools that OIS platforms provide, enabling healthcare professionals to enhance patient outcomes and optimize treatment efficiency.

Key Market Trends & Insights

• The software segment dominated the market with the largest share of 73.64% in 2024. Oncology information software enables seamless communication and sharing of patient information across healthcare organizations, bridging the gap between practitioners, oncologists, and radiology centers. These platforms play a critical role in improving treatment safety, streamlining workflow, and supporting clinical decision-making. Major companies such as Varian (Siemens Healthineers), Flatiron Health, and Elekta are investing in the development of innovative oncology-specific electronic medical record (EMR) systems to improve cancer patient management and support personalized treatment approaches.
• The medical oncology segment accounted for the largest share of 60.98% in 2024. This segment is essential in delivering a holistic and effective approach to cancer treatment. With the increasing prevalence of cancer in the U.S., medical oncology has become central to therapy strategies, encompassing chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. The rising usage of these therapies is expected to further contribute to the growth of oncology information systems as they support monitoring, treatment planning, and patient-specific customization.
• The hospitals and diagnostic imaging centers segment dominated the market with the largest revenue share of 47.24% in 2024. The adoption of OIS within hospitals is mainly driven by the need to reduce the overall cost of oncology care. Manual workflows and fragmented patient data significantly increase costs and inefficiencies, whereas OIS platforms help to integrate data, improve collaboration, and enhance operational efficiency. Hospitals continue to be the primary point of cancer treatment, reinforcing their dominance in the market.
• The ablation care centers and cancer care centers segment is expected to register the fastest CAGR between 2025 and 2030. The expansion of cancer services across specialized care centers is being driven by the growing need for accessible and advanced cancer treatment. For example, in November 2024, UT Southwestern Medical Center announced the expansion of its oncology services in the Fort Worth Medical District with the construction of a new USD 177 million radiation oncology campus. This facility will focus on advanced therapies, including MRI-guided precision radiation treatment, which underlines the growing adoption of technologically advanced OIS solutions.

Order a free sample PDF of the U.S. Oncology Information Systems Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 900.29 million
• 2030 Projected Market Size: USD 1.38 billion
• CAGR (2025 - 2030): 7.40%

Key Companies & Market Share Insights

Key players operating in the U.S. oncology information systems market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Key Players

• Elekta AB
• Accuray Incorporated
• Varian Medical Systems (Siemens Healthineers)
• RaySearch Laboratories
• Cerner Corporation (Oracle Corporation)
• BrainLab
• Philips Healthcare
• Prowess, Inc.
• DOSIsoft S.A.
• ViewRay Inc.
• MIM Software
• Flatiron

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. oncology information systems market is witnessing robust growth, fueled by the rising cancer incidence, increasing healthcare IT integration, and the growing demand for personalized treatment solutions. Hospitals currently dominate the market due to higher adoption rates, while specialized cancer care centers are projected to grow rapidly with expanding oncology service offerings. The market’s future growth will be shaped by innovation in oncology-specific EMR systems, integration of decision support tools, and enhanced data-sharing capabilities. With cancer prevalence expected to rise, OIS adoption will play a critical role in optimizing patient outcomes, reducing costs, and driving precision-driven oncology care across the U.S.